The demand for long-acting reversible contraception increased after the election of President TrumpDonald TrumpJulian Castro knocks Biden administration over refugee policy Overnight Energy & Environment — League of Conservation Voters — Climate summit chief says US needs to 'show progress' on environment Five takeaways from Arizona's audit results MORE in November of 2016, according to a new study released Monday.
The study, published in the Journal of the American Medical Association, found a 21.6 percent increase in the insertion rates of long-acting reversible contraception, like IUDs and implants, in the 30 days after Trump was elected.
The authors of the study said the increase could be attributed to fears that Trump would follow through on his campaign promise to repeal ObamaCare, which requires employers cover 18 types of contraception in their insurance plans with no copays for beneficiaries.
The cost of an IUD without insurance coverage can range from $500 to $1,000, according to Planned Parenthood.
While the GOP's efforts to repeal ObamaCare have failed, the administration has tried to issue rules broadening exemptions for employers that have moral or religious objections to providing contraception for their employees.
Those rules have been blocked from taking effect while they are challenged in court.
The study examined insertion rates among women 18-45 years old enrolled in commercial insurance during the 30 days before and after Nov. 8, 2016, and compared it to the same time frame the year prior.
If the study's findings were projected to the 33 million women between the ages of 18 and 45 with employer-sponsored health insurance, the rate would be an additional 700 insertions per day in association with the 2016 election, the authors say.